CiteNScope — Scholarly Index & Analytics
Discover / IJRBSPUBLICATION RECORD

Advertising to the End Consumers by Pharmaceutical Companies

Scott Goldberg

International Journal of Research in Business and Social Science · 2013 · Vol. 2 / Issue 4 · 60-71

Research reach

Publication metrics

External links open provider records or DOI searches. Provider counts are not combined. Mendeley readership measures saves, not citations.

Dimensions

Live provider badge. If unavailable, use the Dimensions link above.

CROSSREF CITATIONS1

Observed 21 Oct 2026, 07:22 UTC

OpenAlex · Citations3Cached provider observation

Observed 21 Oct 2026 00:49 UTC

Mendeley · Readers—No verified count available

OpenAlex and Mendeley observations refresh on article visits, at most once per 24 hours. Unavailable data is not zero. Google Scholar opens a DOI search.

OpenAlex / Citation year

Annual citations to this article

View provider totals ↑

Citations received by this article, grouped by the year of the citing work. Crossref and OpenAlex lifetime totals remain separate in Publication metrics.

2017–2026 Annual history last updated:

Citations received

OpenAlex · year of the citing work

OpenAlex

Hover over a year or focus the chart and use arrow keys to inspect values.

2017–2026 annual-history window. 2026 is year to date. Unknown years have gaps.

View data & coverage

2026 is incomplete. Within a successfully fetched ten-year window, omitted years mean zero. Years beyond a saved observation’s window remain unknown (—). Older citations are excluded, so this chart’s sum may differ from the OpenAlex lifetime total. The date above belongs to this annual history; an unsuccessful refresh keeps the previous observation.

Overview

Abstract


 
 
 The last several years have seen an increase in the number of direct to consumer advertisements by pharmaceutical companies. Direct to Consumer advertisements (DTC) means targeting the end consumer through advertisements on television, radio, in newspapers, magazines, and the Internet. The qualitative study presents data and supports the need for a future quantitative study to ask physicians and consumers their opinions on whether pharmaceutical companies should be allowed to advertise directly to the end consumer. This article reviews the literature on this controversial topic, supporting the need to explore the reserach questions in greater detail. A review of the literature suggests there is financial motivation on the part of the pharmaceutical companies to increase their sales by advertsing directly to the end consumer as opposed to performing an educational service to the consumer.
 
 

Keywords: {'name': 'Advertising'}, {'name': 'Pharmaceutical'}, {'name': 'Ethical Issues'}, {'name': 'Corporate Responsibility'}, {'name': 'Marketing'}

Authors & affiliations

Scott Goldberg
Affiliation not supplied

Deposited references

Supplied references, not a list of publications citing this article.

Adams, M. (2005,). Direct to consumer advertising must be banned as part of FDA reform. Retrieved from http://www.newstarget.com/003204.html

Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes and behaviors associated with DTCA promotion of prescription drugs. Summary of FDA survey research results: U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research.

Anthony, P. (2005). Direct to consumer drug advertising. Paul chief medical officer phar.FDA congressional testimony, Senate special again committee, 1-6

Barbera, C. L. (Fall, 2012). Irresponsible reminders: Ethical aspects of direct-to-consumer drug advertising. Ethics &

& Medicine. 28.3. 95-112.

Beirne, M. (12). In the name of responsibility. Brandweek, 44, 32-37.

DOI: 10.1046/j.1525-1497.1999.01049.x

DOI: 10.3200/HTPS.83.4.32-36

Chockley, N. (July 24, 2001). The emerging impact of direct-to consumer prescription drug advertising. Testimony of Nancy Chockley, President National Institute for Health Care Management Research and Educational Foundation (NIHCM Foundation): Before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism of the Senate Committee on Commerce, Science and Transportation, Washington, D.C.

First Amendment. (n.d.). First amendment. Retrieved March 12, 2006, from www.http://firstammendmentcenter.org Frank, R. E., Berndt, E. R., Donahue, J., Epstein, A., & Rosenthal, M. (February, 2002). Trends in direct to consumer

advertising in prescription drugs (1): The Henry J. Kaiser Family Foundation.

DOI: 10.1001/jama.2012.182

data? JAMA 307:8. 787

DOI: 10.1177/0196859905285315

Hunt, M. (1998). Direct to consumer advertising of prescription drugs. Report the George Washington University Health Policy Forum, April.

DOI: 10.1377/hlthaff.23.4.143

Kotler, P., & Keller, K.L. (2007). A framework for marketing. (3rd ed.). Upper Saddle River: Prentice Hall. p 340.

Lane, W.R., King, K.W., Russell, J.T. (2005). Kleppner’s advertising procedure (16th ed.). Upper Saddle River: Pearson Hall. p. 705

Lee, R. (2001). Direct to consumer advertising. Orthopedic technology review, 3(1), 30. Retrieved from http://www.orthopedictechreview.com/issues/janfeb01/pg30.htm

DOI: 10.1007/BF03256813

DOI: 10.1080/10410236.2011.556084

Martin, S. (2001). Like a rocket: Direct to consumer drug ad spending. Retrieved from http://my.webmd.com/content/article/12/1691_51055.prinitingtrue.

DOI: 10.1016/j.jbusres.2009.10.004

Mercola, Dr. J. (2002, February 27). Drug companies triple money on direct-to-consumer ads. Retrieved 01232006, from http://mercola.com/2002/feb/27/drug_ads.htm

Moynihan, R., & Cassels, A. (2005, October 17). A disease for every pill .The Nation, 281, 22-25

Sherer, R. A. (2002, May). Does DTC Advertising Benefit Patients? Psychiatric times, XIX, 1-6. Retrieved from

http://psychiatrictimes.com

Smith, S. (2005, November 1). Bookshelf: selling sickness. Retrieved from http://prorev.com/2005/11/bookshelf.htm

DOI: 10.1108/EUM0000000005935

Thomaselli, R. (February 20, 2006). Selling drugs:GLAXO'S crafty plan. Advertising Age, p, 21.

DOI: 10.1111/j.1745-7599.2003.tb01312.x

medications? Journal of the Academy of Nurse Practitioners, 15(7), 297-304.

Weissman, J.S., Blumenthal D., Silk, K., Zapet, K., Newman M., Leitman, R., (2003). Consumer’s reports on health

effects of direct to consumer drug advertising. Health Affairs, 4, 219-233.

DOI: 10.1377/hlthaff.19.2.110

Impact, and Implications. Health Affairs, 19(2), 110-128.

Wood, D. J. (2006, January 3). Ad issues to watch for in "06. Advertising Age, January 12, 2006. p. 1